You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories/Geisinger Proven Diagnostics Test Catalog
RESPIRATORY PATHOGEN PANEL, PCR |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB3004 Geisinger Epic ID: 47176 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Nasopharyngeal (NP) swab is the preferred/optimal specimen used for pre-admission testing and diagnosis. Other acceptable specimen types for diagnostic purposes include, NP wash/aspirate, BAL, bronch wash, throat swab, tracheal wash/aspirate, NOTE: Suboptimal specimen types include: nasal swab, nares swab, nose swab. Do NOT collect these sample types for inpatient testing, pre-admission or diagnostics. The accuracy of testing from these sample types is lower. | |
Preferred collection container: |
||
Alternate Collection Container: |
Other manufacturer's viral transport medium
|
|
Special notes: |
Check expiration date on collection/transport device before use. Refer to Virology Collection Appendix for collection instructions.
BAL, bronch wash, trach aspirate or NP wash, aspirate specimens: Add 1 mL of specimen to VTM within one (1) hour of collection. |
|
| SPECIMEN PROCESSING |
||
Transport temperature: |
Refrigerated (2-8°C) | |
Specimen stability: |
Stable 3 days at refrigerated temperatures (2-8°C). Stable for 24 hours at room temperature (15-25°C). Stable for 30 days frozen (-70°C). | |
Rejection criteria: |
Specimens stored or transported at incorrect temperature. Specimens not in viral transport medium. Improperly labeled/identified specimens. Specimens collected on wooden shafted swab. Expired transport medium. Specimens which exceed stability limits. Quantity of specimen insufficient. Improper specimen type. Sputum specimens are not acceptable. Frozen specimens. | |
TEST DETAILS |
||
Reference interval: |
Negative for all analytes tested | |
Critical values/courtesy alerts: |
Specific analyte RNA/DNA detected by PCR (Amplified Probe) | |
Additional information: |
See Respiratory Flow Diagram. | |
CPT code(s): |
0202U | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Molecular detection of analyte RNA/DNA from approved respiratory specimens. This assay detects and identifies the following analytes: Influenza A virus (H1, H3, 2009 H1 and non-subtypeable), influenza B virus, respiratory syncytial virus, parainfluenza virus types 1, 2, 3, and 4, human metapneumovirus, rhinovirus, adenovirus, coronaviruses: HKU1, NL63, 229E, OC43 and SARS-CoV-2, Bordetella pertussis, Bordetella parapertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae. | |
Methodology: |
Multiplex polymerase chain reaction (PCR) |
|
Synonyms: |
Comprehensive viral studies, viral culture, PCR, influenza A, repiratory pathogen (PCR) influenza B, RSV, respiratory syncytial virus, parainfluenza virus, viral PCR viral panel, respiratory viral panel, adenovirus, human metapneumovirus, rhinovirus, swine flu, novel flu, parainfluenza 4, coronavirus, coronavirus HKU1, coronavirus NL63, coronavirus 0C43, coronavirus 229E, SARS-CoV-2, FilmArray, multiplex PCR, Respiratory PCR, Bordetella pertussis, Bordetella parapertussis, Chlamydophila pneumoniae, Mycoplasma pneumoniae, walking pneumonia, community acquired pneumonia, bacterial pneumonia, respiratory pathogen PCR RPPCR
|
|
Clinical significance: |
Respiratory pathogens cause acute local and systemic disease of varying severity, with the most severe cases occuring in children, the elderly, and immunocompromised individuals. Due to the similarity of diseases caused by many viruses and bacteria, diagnosis based on clinical symptoms alone is difficult. Identification of potential causitive agents provides data to aid the physician to determine appropriate patient treatment and public health response for disease containment. | |
Doctoral Director(s:) |
Donna Wolk PhD, D(ABMM), Raquel Martinez, PhD, D(ABMM) | |
| Review Date: | 12/31/2022 | |
Performing Locations
Geisinger Wyoming Valley Medical Center
Geisinger Shamokin Area Community Hospital
Geisinger Community Medical Center
Geisinger Medical Center Muncy